Most online weight-loss pages answer the question their seller wants asked: “How quickly can I begin?” A careful buyer has a different list. Who evaluates me? What exactly am I paying for? Which pharmacy fills the prescription? What happens after the introductory price ends—and what happens if I am not prescribed the product pictured?
Those questions matter because “GLP-1 program” is not one standardized product. One company may charge a clinical membership and send a brand-name prescription to an outside pharmacy. Another may quote a bundled cash price for clinician review, a compounded drug, supplies, and delivery. A third may focus on insurance authorization while leaving the medication copay outside its headline.
Start with the ordinary recurring total
Write down five numbers: the first charge, the normal renewal, the medication charge, required labs, and shipping. Note whether the displayed monthly figure is actually an annual or multi-month purchase divided by the number of months. If a site says “from” or “as low as,” treat that as a lead—not the answer.
For example, Ro’s official weight-loss page separates its Body membership from medication cost. OrderlyMeds’ pricing page presents bundled compounded-product prices and distinguishes starter offers from ongoing rates. Neither structure is inherently better; they simply cannot be compared with one number unless the components are normalized.
Trace the care chain
Ask for the legal medical group, clinician, and dispensing pharmacy. They can be different from the brand on the homepage. Confirm whether follow-up means scheduled visits, asynchronous messages, a care coordinator, or only customer support. “Access to a provider” is not precise enough when you are trying to understand who manages side effects, refill decisions, or a change in medical history.
The FDA says unapproved GLP-1 products do not undergo its review for safety, effectiveness, or quality. If a program advertises a compounded product, the profile should say that plainly and name the pharmacy route where possible. Approval of a branded drug does not turn a compounded version into an FDA-approved product.
Match the program to the actual job
A first-time patient may value a fuller intake, coaching, and insurance help. Someone switching providers may care more about record transfer, current-dose review, and avoiding a refill gap. A cash buyer may favor a predictable bundled total; an insured buyer may tolerate more administrative work for a lower net pharmacy cost. The useful comparison is not “best provider.” It is “best-documented fit for this access problem.”
Check the commercial context
An affiliate link can be a legitimate way for a publication to earn revenue, but the relationship should be obvious. The FTC advises that material connections be disclosed clearly and close to the endorsement. GLP.directory keeps payout out of its matcher score and labels compensated destinations on the profile.
Before paying, save the offer page and cancellation terms. Then ask the provider to confirm the ordinary recurring total, medication path, pharmacy, and state availability. A calm ten-minute check is more valuable than a crowded page of star ratings.
Use one comparison sheet, not twenty browser tabs
A useful comparison has one row for each question and one column for each provider. Start with the facts that can change the practical outcome: amount due today, ordinary renewal, clinician access, advertised medication route, dispensing pharmacy, required laboratory work, shipping, state availability, cancellation window, and the charge if no prescription is issued. Leave a cell blank when the answer is not public. “Not confirmed” is more accurate than filling a gap with an assumption.
The 15-minute screen
Separate four decisions that marketing often blends together
| Decision | Evidence to look for | What it does not prove |
|---|---|---|
| Clinical eligibility | A licensed-clinician evaluation and stated intake process | That every applicant receives a prescription |
| Product access | A named advertised route and dispensing process | That the product is in stock or appropriate for you |
| Insurance coverage | A benefit check or prior-authorization workflow | That your plan covers the drug or sets a particular copay |
| Affordability | Normal renewal plus every required component | That the first or lowest displayed number will recur |
This separation also makes the provider matcher more useful. A reader who wants insurance navigation rather than a cash bundle is solving a different access problem from a reader who needs a documented provider transfer.
Score disclosure quality before scoring the offer
Give one point for each answer that is easy to find, specific, dated where necessary, and consistent between the landing page, checkout, and terms. Deducting points for missing disclosure is often more defensible than judging a care experience you have not received. A provider can have a higher price and still make the purchase easier to understand; another can have an attractive headline but leave the renewal or pharmacy unclear.
Recheck at the moment that matters
A directory profile is a research shortcut, not a live eligibility or inventory system. Open the cited source before paying. Save the offer and terms, and ask support to confirm any material ambiguity in writing. For medical questions, use the clinician; for label, storage, or dispensing questions, use the pharmacy; for coverage, use the insurer or benefit manager. The quality of the answer depends on asking the entity that owns it.
Sources: FDA, “FDA’s Concerns with Unapproved GLP-1 Drugs Used for Weight Loss”; FTC, “Disclosures 101 for Social Media Influencers”; official Ro and OrderlyMeds program pages. Sources checked September 10, 2026.
Source ledger
Primary and first-party sources
- U.S. Food and Drug Administrationfda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss ↗
- Federal Trade Commissionftc.gov/business-guidance/resources/disclosures-101-social-media-influencers ↗
- ro.coro.co/weight-loss ↗
- orderlymeds.comorderlymeds.com/pricing ↗
These links support specific facts; inclusion is not an endorsement. Terms can change after the review date.
This report is general information, not medical advice. A licensed clinician who knows your history should guide treatment, prescribing, dosing, and switching decisions. Compounded drugs are not FDA approved.